Zymeworks Inc. (ZYME) stock analysis
ZYME · Zymeworks Inc.
Latest recorded price: USD 25.84
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth -36.4%, free cash flow margin -32.6%, ROIC -14.4%. The model flags 2 risk signals for this company (1 high severity).